Sartorius Stedim Biotech Announces Share and Voting Rights Details

Sartorius Stedim Biotech SA has released its latest report on the number of shares and voting rights comprising its issued capital. As of March 31, 2025, the company has an issued capital made up of 97,330,405 shares. These shares generate a total of 165,559,208 theoretical voting rights, including those attached to treasury shares. Notably, when excluding treasury shares, the total number of net voting rights stands at 165,517,493.

This announcement falls under the regulatory framework of Article L 233-8-II of the French Code of Commerce and Article 223-6 of the AMF's general regulations. The data was disseminated by EQS Group as part of a French Regulatory News publication, holding importance for stakeholders monitoring the company's capital structure.